Today is July 01, 2024. All times in Eastern Daylight Time.
Denodo intègre les microservices d'inférence NIM de NVIDIA pour accélérer et optimiser les capacités d'IA pour les entreprises
06/02/2024 - 07:39 PM
BUSINESS WIRE
Samenvatting: Denodo integreert NVIDIA NIM Inference Microservices om AI-mogelijkheden voor ondernemingen te versnellen en te optimaliseren
06/02/2024 - 07:08 PM
BUSINESS WIRE
Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock
06/02/2024 - 07:00 PM
BUSINESS WIRE
New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
06/02/2024 - 06:00 PM
BUSINESS WIRE
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
06/02/2024 - 05:30 PM
BUSINESS WIRE
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
06/02/2024 - 02:32 PM
BUSINESS WIRE
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination
06/02/2024 - 12:30 PM
BUSINESS WIRE
Stronger Than Ever: Adani Portfolio Delivers Record Performance
06/02/2024 - 12:09 PM
BUSINESS WIRE
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
06/02/2024 - 10:56 AM
BUSINESS WIRE
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
06/02/2024 - 10:01 AM
BUSINESS WIRE
1
...
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
« Previous
Next »